Sep 28

PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer

2500 - Biomarker Analysis of Iruplinalkib Combined with Chemoradiotherapy in ALK+ Unresectable Stage ? Non-Small Cell Lung Cancer

04:45pm - 06:00pm PT

Hall F

Presenter(s)

Linlin Wang, MD, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan,